2024 annual financial data

BriaCell Therapeutics Corp. 2024 Operating margin

BriaCell Therapeutics Corp. 2024 operating margin with verified reported values.

Direct answer

Operating margin was Not calculable.

Operating income was -33,342,711 USD and net income was -4,793,281 USD.
Operating cash flow was -32,967,871 USD.

Get free BriaCell Therapeutics Corp. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-33,342,711 USD
Net income
-4,793,281 USD
Operating cash flow
-32,967,871 USD